Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards

Garg, S; Ferguson, S; Chewning, B; Gomez, S; Keevil, J; Bartels, C

Garg, S (通讯作者),Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Rheumatol, Madison, WI 53706 USA.

LUPUS SCIENCE & MEDICINE, 2023; 10 (2):

Abstract

Background Up to 83% of patients with SLE stop taking hydroxychloroquine (HCQ) within the first year due to knowledge gaps regarding the survival bene......

Full Text Link